Ligand Pharma Financial Overview
Ligand Pharma's market cap is currently $3.83B. The company's EPS TTM is $3.09; its P/E ratio is 95.50; Ligand Pharma is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $1.50. See an overview of income statement, balance sheet, and cash flow financials.
